HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Liang, K ^a   Kim, C H ^a   Vaziri, N D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 hydroxy 3 methylglutaryl; Atherosclerosis; Bile acid; Cholesterol; Lipid disorders; Renal disease; SRB 1; Triglyceride

Indexed keywords

APOLIPOPROTEIN B; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; ROSUVASTATIN; STATINE; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE COURSE; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERTRIGLYCERIDEMIA; KIDNEY DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR;

EID: 14044258727     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00074.2004     Document Type: Article

References (38)

1. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, and Krieger M. Identification of scavenger, receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520, 1996.
2. Anderson RA, Joyce C, Davis M, Reagan JW, Clark M, Shelness GS, and Rudel LL. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem 273: 26747-26754, 1998.
3. Attman PO, Samuelsson O, and Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 21: 573-592, 1993.
4. Bianchi S, Bigazzi R, Caiazza A, and Campese VM. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 41: 565-570, 2003.
5. Carr TP, Hamilton RL Jr, and Rudel LL. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J Lipid Res 36: 25-36, 1995.
6. Cases S, Novak S, Zheng YW, Myers HM, Lear SR, Sande E, Welch CB, Lusis AJ, Spencer TA, Krause BR, Erickson SK, and Farese RV Jr. ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J Biol Chem 243: 26755-26764, 1998.
7. Chan MK, Varghese Z, and Moorhead JF. Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 19: 625-637, 1981.
8. Chang CC, Huh HY, Cadigan KM, and Chang TY. Molecular cloning and functional expression of human acyl-coenzyme Axholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J Biol Chem 268: 20747-20755, 1993.
9. Cianflone KM, Yasruel Z, Rodriguez MA, Vas D, and Sniderman AD. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res 31: 2045-2055, 1990.
10. Genest J Jr, Marcil M, Denis M, and Yu L. High density lipoproteins in health and in disease. J Investig Med 47: 31-42, 1999.
11. Guarnieri GF, Moracchiello M, Campanacci L, Ursini F, Ferri L, Valente M, and Gregolin C. Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia. Kidney Int 13, Suppl 8: S26-S30, 1978.
12. Hahn R, Oette K, Mondorf H, Finke K, and Sieberth HG. Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 48: 279-288, 1983.
13. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, and Teschan PE. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997.
14. Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, and Blasetto JW. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol 92: 152-160, 2003.
15. Keane WF. Lipids and progressive renal failure. Wien Klin Wochenschr 108: 420-424, 1996.
16. Klein RL and Rudel LL. Cholesterol absorption and transport in thoracic duct lymph lipopioteins of nonhuman primates. Effect of dietary cholesterol level. J Lipid Res 24: 343-356, 1983.
17. Klin M, Smogorzewski M, Ni Z, Zhang G, and Massry SG. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J Clin Invest 97: 2167-2173, 1996.
18. Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, and Kastelein J. The molecular pathology of lecithin: cholesterol acyltransferase (LCAT) deficiency syndrome. J Lipid Res 38: 191-205, 1997.
19. Liang KH, Oveisi F, and Vaziri ND. Gene expression of hepatic cholesterol 7α-hydroxylase in the course of puromycin-induced nephrosis. Kidney Int 49: 855-860, 1996.
20. Liang K, Oveisi F, and Vaziri ND. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Kidney Int 53: 626-630, 1998.
21. Liang K and Vaziri ND. Downregulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. Kidney Int 56: 621-626, 1999.
22. Liang K and Vaziri ND. HMG-CoA reductase, cholesterol 7α-hydroxylase, LCAT, ACAT, LDL receptor and SRB-1 in hereditary analbuminemia. Kidney Int 63: 192-198, 2003.
23. Liang K and Vaziri ND. Upregulation of acyl-CoA:cholesterol acyltransferase in chronic renal failure. Am J Physiol Endocrinol Metab 283: E676-E681, 2002.
24. McLeod R, Reeve CE, and Frohlich J. Plasma lipoproteins and lecithin: cholesterol acyltransferase distribution in patients on dialysis. Kidney Int 25: 683-688, 1984.
25. Oda H and Keane WF. Recent advances in statins and the kidney. Kidney Int Suppl 71: S2-S5, 1999.
26. Oelkers P, Behari A, Cromley D, Billheimer JT, and Sturley SL. Characterization of two human genes encoding acyl-coenzyme Axholesterol acyltransferase-related enzymes. J Biol Chem 273: 26765-26771, 1998.
27. Oschry Y and Eisenberg S. Rat plasma lipoproteins: re-evaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity. J Lipid Res 23: 1099-1106, 1982.
28. Shoji T, Nishizawa Y, Nishitani H, Billheimer JT, and Sturley SL. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 41: 1653-1661, 1992.
29. Vaziri ND and Liang K. Down-regulation of hepatic LDL receptor expression in experimental nephrosis. Kidney Int 50: 887-893, 1996.
30. Vaziri ND and Liang K. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int 50: 1928-1935, 1996.
31. Vaziri ND and Liang K. Down-regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int 51: 913-919, 1997.
32. Vaziri ND and Liang KH. Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis. Kidney Int 48: 1979-1985, 1995.
33. Vaziri ND and Liang KH. Upregulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome. Kidney Int 61: 1769-1775, 2002.
34. Vaziri ND, Liang K, and Parks JS. Downregulation of leeithin:cholesterol acyltransferase (LCAT) in chronic renal failure. Kidney Int 59: 2192-2196, 2001.
35. Vaziri ND, Ni Z, Wang XQ, Oveisi F, and Zhou XJ. Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol Renal Physiol 274: F642-F649, 1998.
36. Vaziri ND, Sato T, and Liang K. Molecular mechanism of altered cholesterol metabolism in focal glomerulosclerosis. Kidney Int 63: 1756-1763, 2003.
37. Vaziri ND, Wang XQ, and Liang K. Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. Am J Physiol Renal Physiol 273: F925-F930, 1997.
38. Warnick GR and Cheung MC. Measurement and clinical significance of high density lipoprotein cholesterol subclasses (2nd ed.). In: Handbook of Lipoprotein Testing, edited by Rafai N, Warnick GR, and Dominiczak MH. Washington, DC: AACC, 2000, p. 311-328.